Our news

  • We are delighted to introduce our new Joint Co-ordinating Editor, Dr Neil O’Connell. Dr Neil O’Connell is a Senior Lecturer in the Department of Clinical Sciences at Brunel University, London, UK. He is the author of 16 Cochrane Reviews and has been a PaPaS Editor since 2015. He divides his time between research and teaching and previously...
    January 13 2020
  • We'll be at the 2020 IASP Pain World Congress, presenting "Evidence Synthesis for Determining Efficacy and Harm: Identifying a Quality Signal in the Growing Noise", a session on making sense of the increasing weight of evidence. For more information and details on how to register please see here. 
    December 12 2019
  • Prophylactic anti-emetics for patients receiving intravenous opioids in the acute care settingWe are looking for additional author support to join the existing author team in order to develop the protocol/review. The candidate will have some experience of contributing to Cochrane reviews, and will be famiiar with RevMan. The candidate is expected...
    November 29 2019
  • A great opportunity to develop your professional skills and advance your career as a researcher. Become a citizen scientist as part of an IASP Presidential Task Force reviewing studies in which cannabinoids were tested for antinociceptive effects.Prior knowledge of systematic reviews is not required, all training will be provided.To learn more and...
    November 27 2019
  • Our ten most accessed reviews in 2018 are shown below.Congratulations to everyone involved. 1. Physical activity and exercise for chronic pain in adults: an overview of Cochrane Reviews, Louise J Geneen, R Andrew Moore, Clare Clarke, Denis Martin, Lesley A Colvin and Blair H Smith. See full review here. 2. Cannabis-based medicine...
    September 30 2019
  • Our top ten most cited reviews contributing to the 2018 Impact Factor (i.e. those published in 2016 and 2017, and cited in 2018) are shown below.Congratulations to everyone involved.1. Physical activity and exercise for chronic pain in adults: an overview of Cochrane reviews (DOI: 10.1002/14651858.CD011279.pub3), Louise J Geneen, R Andrew Moore,...
    September 30 2019
  • We are proud to announce that the 2018 Impact Factor for PaPaS is 8.316 (76 publications cited 632 times), this is an increase on the 2017 Impact Factor which was 7.286. This means that a review published by PaPaS in 2016 and 2017 was cited, on average, 8.316 times in 2018. Please note this is an unofficial metric calculated by Wiley, publisher of...
    September 24 2019
  • We regularly send out newseletters to keep everyone updated on what Cochrane PaPaS has been doing recently. Please sign up to our newsletter here.Please click here to view our latest newsletter. See below for previous newsletters.Previous newslettersOctober 2019July 2019May 2019February 2019December 2018October 2018June 2018November...
    July 23 2019
  • PaPaS is part of the Cochrane Musculoskeletal, Oral, Skin and Sensory (MOSS) Network. A short film has been made which introduces the team, talks about what has happened so far, and the ambition for what is to come. Watch it here.
    July 16 2019
  • On the 20th June 2019, we published an overview review in the PAIN Journal on the efficacy of pharmacological interventions for children with chronic pain and cancer-related pain (https://bit.ly/313YmCj). The overview summarises the evidence from 23 systematic reviews, including several PaPaS reviews from our NIHR Programme Grant (https://papas....
    June 27 2019

Pages

Subscribe to Our news